A Cyclooxygase-2 Inhibitor NS-398-Enhanced Apoptosis of Esophageal Carcinoma Cell EC9706 by Adjusting Expression of Survivin and Caspase-3

REFERENCES

• Raff MC. Social controls on cell survival and cell death. Nature 1992;356:397–400.
   PubMed Web of Science ®Google Scholar
• Huerta S, Goulet EJ, Livingston EH. Colon cancer and apoptosis. Am J Surg 2006;191:517–526.
   Google Scholar
• Johnson ME, Howerth EW. Survivin: a bifunctional inhibitor of apoptosis protein. Vet Pathol 2004;41:599–607.
   PubMed Web of Science ®Google Scholar
• Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M, Tanigawa N. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res 2000;6:127–134.
   PubMed Web of Science ®Google Scholar
• Satoh K, Kaneko K, Hirota M, Masamune A, Satoh A, Shimosegawa T. Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors. Cancer 2001;92:271–278.
   PubMed Web of Science ®Google Scholar
• Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T, Tanigawa N. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res 1998;58:5071–5074.
   PubMed Web of Science ®Google Scholar
• Song Z, Yao X, Wu M. Direct interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of surviving during taxol-induced apoptosis. J Biol Chem 2003;278:23130–23140.
   PubMed Web of Science ®Google Scholar
• Inoue H, Yokoyama C, Hara S, Tone Y, Tanabe T. Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. Involvement of both nuclear factor for interleukin-6 expression site and cAMP response element. J Biol Chem 1995;270:24965–24971.
   PubMed Web of Science ®Google Scholar
• Jones DA, Carlton DP, McIntyre TM, Zimmerman GA, Prescott SM. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. Curr Opin Cell Biol 1993;268:9049–9054.
   Google Scholar
• Subbaramaiah K, Telang N, Ramonetti JT, Araki R, DeVito B, Weksler BB, Dannenberg AJ. Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res 1996;56:4424–4429.
   PubMed Web of Science ®Google Scholar
• Williams CS, Smalley W, DuBois RN. Aspirin use and potential mechanisms for colorectal cancer prevention. J Clin Invest 1997;100:1325–1329.
   PubMed Web of Science ®Google Scholar
• Wu QM, Li SB, Wang Q, Wang DH, Li XB, Liu CZ. The expression of cox-2 in esophageal carcinoma and its realation to clinicopathologic characteristic. Shijie Huaren Xiahua Zazhi 2001;1:12–14.
   Google Scholar
• Beauchamp RD, DuBois RN. Elevated cyclooxygenase-2 levels in min mouse adenomas. Gastroenterology 1996;111:1134–1140.
   PubMed Web of Science ®Google Scholar
• Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, Wakabayashi N, Saunders B, Shen Y, Fujimura T, Su LK, Levin B, Godio L, Patterson S, Rodriguez-Bigas, M.A., Jester SL, King KL, Schumacher M, Abbruzzese J, DuBois RN, Hittelman WN, Zimmerman S, Sherman JW, Kelloff G. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000;342:1946–1952.
   PubMed Web of Science ®Google Scholar
• Qiu DK, Ma X, Peng YS, Chen XY. Ignificance of cyclooxygenase-2 expression in human primary hepatocellular carcinoma. World J Gastroenterol 2002;8:815–817.
   PubMed Web of Science ®Google Scholar
• Kern MA, Schubert D, Sahi D, Schoneweiss MM, Moll I, Haugg AM, Dienes HP, Breuhahn K, Schirmacher P. Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells. Hepatology 2002;36(4 Pt 1):885–894.
   PubMed Web of Science ®Google Scholar
• Cheng J, Imanishi H, Amuro Y, Hada T. NS-398, a selective cyclooxygenase 2 inhibitor, inhibited cell growth and induced cell cycle arrest in human hepatocellular carcinoma cell lines. Int J Cancer 2002;9:755–761.
   Google Scholar
• Hara A, Yoshimi N, Niwa M, Ino N, Mori H. Apoptosis induced by NS-398, a selective cyclooxygenase-2 inhibitor, in human colorectal cancer cell lines. Jpn J Cancer Res 1997;88:600–604.
   PubMedGoogle Scholar
• Leng J, Han C, Demetris AJ, Michalopoulos GK, Wu T. Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis. Hepatology 2003;38:756–768.
   PubMed Web of Science ®Google Scholar
• Naoko S-O, Fumi T-Y, Kazuhiro F, Fumie S, Yoji T, Yoshikazu M, Sachio M, Mitsuo I, Toshiyuki S. Celecoxib inhibits the expression of survivin via the suppression of promoter activity in human colon cancer cells. Biochem Pharmacol 2007;73:1318–1329.
   PubMed Web of Science ®Google Scholar
• Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Heath CWJ. Aspirin use and risk of fatal cancer. Cancer Res 1993;53:1322–1327.
   PubMed Web of Science ®Google Scholar
• Gupta RA, DuBois RN. Aspirin, NSAIDS, and colon cancer prevention: mechanisms? Gastroenterology 1998;114:1095–1098.
   PubMed Web of Science ®Google Scholar
• Cheng T, Cao W, Wen R, Steinberg RH, LaVail MM. Prostaglandin E2 induces vascular endothelial growth factor and basic fibroblast growth factor mRNA expression in cultured rat Müller cells. Invest Ophthalmol Vis Sci 1998;39:581–591.
   PubMed Web of Science ®Google Scholar
• Zimmermann KC, Sarbia M, Weber AA, Borchard F, Gabbert HE, Schror K. Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res 1999;59:198–204.
   PubMed Web of Science ®Google Scholar
• Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995;83:493–501.
   PubMed Web of Science ®Google Scholar
• Han JA, Kim J-I, Ongusaha PP, Hwang DH, Ballou LR, Mahale A, Aaronson SA, Lee SW. p53-mediated induction of COX-2 counteracts p53- or genotoxic stress-induced apoptosis. EMBO J 2002;21:5635–5644.
   PubMed Web of Science ®Google Scholar
• Sheng HM, Shao J, Kirkland SC, Isakson P, Coffey RJ, Morrow J, Beauchamp RD, DuBois RN. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest 1996;99:2254–2259.
   Web of Science ®Google Scholar
• Wang Xingpeng, Xu Xuanfu, Wang Bingxian, Regulatory effect of cyclooxygenase-2 on the apoptosis of pancreatic adenocarcinoma cells and its possible mechanism. Zhong hua xiao hua za zhi 2002;22(8):459–462.
   Google Scholar
• Gruter MG. Caspases: key players in programmed cell death. Curr Opin Struct Biol 2000;10:649–655.
   PubMed Web of Science ®Google Scholar
• Shin S, Sung BJ, Cho YS, Kim HJ, Ha NC, Hwang JI, Chung CW, Jung YK, Oh BH. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry 2001;96:1117–1123.
   Google Scholar